A crucial aspect of regenerative treatment and drug discovery lies in the ability to multiply human stem cell collections to sufficient numbers for therapeutic purposes. Traditionally, constrained cell availability posed a significant obstacle to progress in these fields. Consequently, considerable effort has been directed towards optimizing proced